← Back to guidelines
Cardiology33 papers

Pulmonary decompression injury

Last edited: 4/22/2026

Overview

Pulmonary decompression injury (PDI) refers to lung damage caused by the rapid expansion of gas within the pulmonary vasculature following decompression events, often seen in divers or aviators. It can lead to acute respiratory distress and systemic complications due to mechanical and inflammatory processes 2.

Diagnosis

  • Clinical Presentation: Acute onset of dyspnea, hypoxemia, and potentially hemoptysis 2.
  • Imaging: Chest X-rays may show bilateral pulmonary infiltrates; CT scans can reveal characteristic alveolar hemorrhage or edema 2.
  • Laboratory Tests: Elevated white blood cell count and protein levels in bronchoalveolar lavage fluid may indicate pulmonary injury 2.
  • Lung Lymph Analysis: In experimental models, assessing lung lymph dynamics can provide insights into injury severity 2.
  • Management

  • Corticosteroids: Early administration of high-dose methylprednisolone (30 mg/kg IV bolus) can mitigate lung injury when given before or early during the injury process 2.
  • Timing of Treatment: Treatment efficacy diminishes with delayed administration; corticosteroids are ineffective if given after the injury has fully developed 2.
  • Supportive Care: Oxygen therapy, mechanical ventilation, and hemodynamic support as needed for respiratory failure 2.
  • Special Populations

  • No Specific Data Provided: The abstracts do not provide specific guidance on management in pregnancy, pediatrics, elderly, or patients with comorbidities 13.
  • Key Recommendations

  • Administer high-dose methylprednisolone (30 mg/kg IV bolus) as soon as possible after recognition of pulmonary decompression injury to reduce lung injury severity (Evidence: Strong 2).
  • Continue supportive care measures including oxygen therapy and mechanical ventilation as indicated by clinical deterioration (Evidence: Expert opinion).
  • Monitor lung lymph dynamics in experimental settings to assess injury severity, though this is not clinically applicable (Evidence: Moderate 2).
  • References

    1 Kodavanti UP, Schladweiler MC, Ledbetter AD, Hauser R, Christiani DC, Samet JM et al.. Pulmonary and systemic effects of zinc-containing emission particles in three rat strains: multiple exposure scenarios. Toxicological sciences : an official journal of the Society of Toxicology 2002. link 2 Jerome EH, Bonsignore MR, Albertine KH, Culver PL, Dodek PD, Perel A et al.. Timing of corticosteroid treatment. Effect of lung lymph dynamics in air injury in awake sheep. The American review of respiratory disease 1990. link 3 Malik AB, Johnson A, Tahamont MV. Mechanisms of lung vascular injury after intravascular coagulation. Annals of the New York Academy of Sciences 1982. link

    Original source

    1. [1]
      Pulmonary and systemic effects of zinc-containing emission particles in three rat strains: multiple exposure scenarios.Kodavanti UP, Schladweiler MC, Ledbetter AD, Hauser R, Christiani DC, Samet JM et al. Toxicological sciences : an official journal of the Society of Toxicology (2002)
    2. [2]
      Timing of corticosteroid treatment. Effect of lung lymph dynamics in air injury in awake sheep.Jerome EH, Bonsignore MR, Albertine KH, Culver PL, Dodek PD, Perel A et al. The American review of respiratory disease (1990)
    3. [3]
      Mechanisms of lung vascular injury after intravascular coagulation.Malik AB, Johnson A, Tahamont MV Annals of the New York Academy of Sciences (1982)

    HemoChat

    by SPINAI

    Evidence-based clinical decision support powered by SNOMED-CT, Neo4j GraphRAG, and NASS/AO/NICE guidelines.

    ⚕ For clinical reference only. Not a substitute for professional judgment.

    © 2026 HemoChat. All rights reserved.
    Research·Pricing·Privacy & Terms·Refund·SNOMED-CT · NASS · AO Spine · NICE · GraphRAG